HR-10234-119
Referred to the House Committee on Financial Services.
Sponsored by Zachary Nunn (R-IA)
What it does
This bill would require the Securities and Exchange Commission to create new standardized registration forms for certain registered non-variable insurance products, including contingent deferred annuities and registered index-linked life insurance. The SEC would have 12 months to propose the forms and 30 months to finalize them, with a fallback provision allowing issuers to use existing similar forms if the SEC misses the deadline. The bill directs the SEC to design forms based on investor testing and to limit disclosure requirements to those already used for similar existing products.
Who benefits
Insurance companies and issuers of contingent deferred annuities and registered index-linked life insurance, who would gain a standardized, predictable registration process instead of relying on ad hoc SEC guidance; purchasers of these products, who supporters say would benefit from clearer, tested disclosures; and financial services trade groups representing insurers seeking regulatory certainty.
Who is hurt
No group is meaningfully harmed by this bill's mechanics, though the SEC would bear implementation costs and staff time to develop and test new forms, and issuers may face short-term compliance costs adapting to new form requirements once finalized. Consumer advocates who believe disclosure alone is insufficient investor protection may see limited benefit from the change.
Supporters argue
Supporters argue that contingent deferred annuities and index-linked life insurance are complex products currently registered on forms designed for other securities, making disclosures harder for ordinary purchasers to understand. They contend that requiring the SEC to develop tested, tailored forms — informed by investor testing — would help purchasers make more informed decisions without creating new substantive regulatory burdens, since the bill explicitly limits disclosures to existing standards used for similar products.
Opponents argue
Opponents argue that imposing a rigid 12-month and 30-month rulemaking deadline may pressure the SEC to finalize forms before adequately testing their effectiveness with real purchasers, undermining the bill's own stated goal of investor comprehension. They contend that legislating specific rulemaking timelines and cross-references to existing CFR forms constrains the SEC's independent judgment about what disclosures best protect investors, potentially locking in disclosure formats that become outdated as these insurance products evolve.